The Right RIA For You. All content copyrighted © 2019 – onwards by Ambastha Financial LLC.
By Kuldip K. Ambastha and Anil K. Ambastha Nearly every time I strayed from the herd, I’ve made a lot of money. Wandering away from the action is the way to find the new action. (Jim Rogers; https://www.goodreads.com/quotes/tag/wall-street) I will tell you the secret to getting rich on Wall Street. You try to be greedy …
By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 18, 2020, Franklin Resources, Inc. (BEN) and Legg Mason, Inc. (LM) made big headlines. Legg Mason returned 24.4% for the day, while Franklin Resources (AKA: Franklin Templeton) returned 6.9%. Why? Franklin Resources is buying Legg Mason, in an all-cash deal valued at $4.5 billion. …
Continue reading “What Caught Our Attention in the Investment World? – Week of February 17-21, 2020”
By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …
Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha Best Buy Co., Inc. (BBY), a big-box electronics retailer business headquartered in Richfield, MN, delivered strong results for 3Q2019. During the quarter, the company exceeded expectations on many fronts, such as earnings, revenues, and same-store sales. The key product and service lines which performed well were tablets, …
Continue reading “What Caught Our Attention in the Investment World? – Week of November 25-29, 2019”
By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …
Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”